Anavex Life Sciences Corp (AVXL)

[jimmy667]

Your reasoning would be sound had some of the most presigious scientist in the field had not looked at the data so far and found it to not just be good but used some specific superlatives to describe their findings. It also does not take into account the new testing protocols from FDA namely Adaptive. But I agree that the statement about "knowing by Missling" is pure conjecture as he has no way to be assured of final success.
FDA has already cleared A2-73 for ph3 DBlind with placebo controled which will determine FDA approval or not. However the results of the current Ph2 Adaptive might be robust enough to reach sat-sig. This might result in a radical revaluation of the company based on analysis of increased probability of success same as any other clinical stage biotech. There are many other potential catalyst that could cause a drastic revaluation. Govt. Grant. BP partnership. Start of new trial. Significant institutional interest. and others forseen and unforseen. All well In advance of Ph3 completion.Charts and candles likely show a bottoming here so if one likes to gamble long on biotech could be great entry or add point. JMHO But I act on it have been buying and holding for a long time and consider these prices of late to be very attractive to available cash. Good luck and thanks for your post. There is no way Missling "knows" it will be successful but I think one can surmise he is very encouraged as are many in the scientific community.